Recently, a novel and highly selective ALDH2 activator, AD-9308, has emerged, demonstrating promising outcomes in addressing diet-induced obesity and fatty liver and enhancing glucose homeostasis in both ALDH2 wild-type and mutation mice (41). This evidence concerns the gene ALDH2 and obesity due to melanocortin 4 receptor deficiency.